Abstract

Host-associated bacteria and fungi, comprising the microbiota, are critical to host health. In the airways, the composition and diversity of the mucosal microbiota of patients are associated with airway health status. However, the relationship between airway microbiota and respiratory inflammation is not well-understood. Chronic rhinosinusitis (CRS) is a complex disease that affects up to 14% of the US population. Previous studies have shown decreased microbial diversity in CRS patients and enrichment of either Staphylococcus aureus or Pseudomonas aeruginosa. Although bacterial community composition is variable across CRS patients, Malassezia is a dominant fungal genus in the upper airways of the majority of healthy and CRS subjects. We hypothesize that distinct bacterial-fungal interactions differentially influence host mucosal immune response. Thus, we investigated in vitro and in vivo interactions between Malassezia sympodialis, P. aeruginosa, and S. aureus. The in vitro interactions were evaluated using the modified Kirby-Bauer Assay, Crystal Violet assay for biofilm, and FISH. A pilot murine model of acute sinusitis was used to investigate relationships with the host immune response. S. aureus and P. aeruginosa were intranasally instilled in the presence or absence of M. sympodialis (n = 66 total mice; 3–5/group). Changes in the microbiota were determined using 16S rRNA gene sequencing and host immune response was measured using quantitative real-time PCR (qRT-PCR). In vitro, only late stage planktonic P. aeruginosa and its biofilms inhibited M. sympodialis. Co-infection of mice with M. sympodialis and P. aeruginosa or S. aureus differently influenced the immune response. In co-infected mice, we demonstrate different expression of fungal sensing (Dectin-1), allergic responses (IL-5, and IL-13) and inflammation (IL-10, and IL-17) in murine sinus depending on the bacterial species that co-infected with M. sympodialis (p < 0.05). The pilot results suggest that species-specific interactions in airway-associated microbiota may be implicated driving immune responses. The understanding of the role of bacterial-fungal interactions in CRS will contribute to development of novel therapies toward manipulation of the airway microbiota.

Highlights

  • Emerging studies of the microbiota, defined as bacteria, fungi, viruses, and archaea that inhabit a niche, have profoundly altered our understanding of the role of the human microbiota in health and disease

  • We investigated the interaction between predominant sinonasal bacterial pathogens, P. aeruginosa and S. aureus, and a dominant fungus present in the upper respiratory tract, M. sympodialis (Findley et al, 2013; Cope et al, 2017)

  • We show that there are species-specific interactions in vitro between a predominant member of sinonasal mycobiota, Malassezia, and major pathobionts associated with CRS (P. aeruginosa or S. aureus), and that co-infections with M. sympodialis and P. aeruginosa or S. aureus leads to distinct immune responses

Read more

Summary

Introduction

Emerging studies of the microbiota, defined as bacteria, fungi, viruses, and archaea that inhabit a niche, have profoundly altered our understanding of the role of the human microbiota in health and disease. The range of effects that these complex microbial assemblages have on human physiology is unimaginably broad. Gut microbes produce propionate and acetic acid, which can act as ligands for G protein-coupled receptors (GPCRs) and affect neutrophil chemotaxis, regulation of regulatory T cells (Treg), and dendritic cell (DC) maturation (Kau et al, 2011; Thaiss et al, 2016). The development of culture-independent methods has shown that complex, sitespecific microbial communities inhabit the upper and lower airways (Brill et al, 2016; Pletcher et al, 2018)

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.